AccreditationACC.19 Statement of Educational Need/Purpose

Despite tremendous advances in recent years, cardiovascular disease (CVD) remains the leading cause of death throughout the world. While ongoing research seeks to further improve outcomes in several areas of CVD, numerous well-defined, evidence-based practices face struggles with implementation.

It is imperative that every member of the cardiovascular team play their role(s) to address these practice gaps and optimize cardiovascular care. Therefore, in this era of rapid transformation, education is essential to update clinicians on the latest science and advances in CVD, facilitate uptake of evolving best practices, and promote practical solutions that support the entire care team.

ACC.19 will provide an engaging and empowering educational environment that offers a contemporary environmental scan, state-of-the-art updates, expert perspectives on challenging clinical decisions, and tools to help clinicians navigate real-world challenges with the collective goal of improving outcomes for patients with cardiovascular disease.

To provide a stimulating environment for information sharing of new knowledge, presentation of research, networking and collaboration with a goal of improving cardiovascular disease management for all patients

To facilitate translation of cardiovascular science to all members of the care team leading to high-quality, patient-centered care

To allow for examination and discussion of important contributions and controversies in cardiovascular care

To integrate traditional and novel educational techniques and create an interactive and informative learning environment

Physicians

The American College of Cardiology Foundation (ACCF) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The ACCF designates this live activity for a maximum of 28 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 28 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

European Board for Accreditation in Cardiology (EBAC) External CME Credit

ACC.19 will be accredited by the European Board for Accreditation in Cardiology (EBAC) for 20 hours of External CME credits. Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME) and the European Board for Accreditation in Cardiology (EBAC) have recognized each other's accreditation systems as substantially equivalent. Apply for credit through the post-course evaluation.

Nurses

The American College of Cardiology Foundation (ACCF) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation (ANCC Provider Number 0019).

The ACCF designates this educational activity for a maximum of 28 continuing nursing education contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists

This activity is eligible for ACPE credit, see final CPE activity announcement for specific details.

Scrutinize the methodology of recent acute and stable ischemic heart disease clinical trials to determine the implications and generalizability of findings

Evaluate the evidence and different perspectives underlying current controversies in acute and stable ischemic heart disease diagnosis and management and ACS Guidelines, including international and other societal guidelines

Describe the management of complications seen in ischemic heart diseases

Discuss barriers to implementation of cardiac rehab and novel approaches

Assess and appropriately manage patients with cardiogenic shock or in need of critical care

Detect and manage patients with angina refractory that are resistant to conventional treatment options

As a result of participating in the Heart Failure and Cardiomyopathies Pathway sessions, learners will have an improved or reinforced ability to:

Integrate contemporary concepts in cardiovascular pathophysiology with evidence-based strategies in the diagnosis, evaluation, and management across the entire spectrum of patients with heart failure and cardiomyopathy

Offer practical guidance on diet, exercise, support, and heart failure management that is appropriately tailored to diverse patient populations across various stages and types of heart failure

Recognize the interaction between various comorbidities and heart failure, and best practices in the multidisciplinary approach

Evaluate the role and indications for ICDs, CRTs, hemodynamic sensors, and mechanical support for heart failure management

Expand knowledge in the evidence-based care of patients with infiltrative and inherited cardiomyopathy, and less common inherited and acquired cardiomyopathies

Analyze the evidence on current and newer pharmacotherapies, devices, and therapies for best practices heart failure management

As a result of participating in the Invasive CV Angiography and Intervention Pathway sessions, learners will have an improved or reinforced ability to:

Determine an appropriate antithrombotic regimen for diverse patients with acute coronary syndrome or undergoing a revascularization procedure, and address issues with antiplatelet regimens in patients at high risk for bleeding

Interpret and integrate findings from adjunctive coronary and endovascular assessment into clinical decision-making

Decide whether and how to revascularize patients who are high-risk or have complex coronary artery disease

Utilize findings from non-invasive imaging to clarify the etiology and guide the management of patients with heart failure or cardiomyopathy and systemic diseases involving the heart (e.g., cardiac amyloidosis, sarcoidosis)

Recognize the prognostic implications of cardiac CT and cardiac MRI findings and their appropriate impact on patient management